P1077: Patients’ and Gastroenterologists’ Preferences on Outcomes and Medication Attributes for Ulcerative colitisECCO'24Year: 2024
Authors: Katsoula, A.(1,2)*;Paschos, P.(2,3);Giouleme, O.(1);Toumbalidou, M.(2);Mainou, M.(2,4);Malandris, K.(2);Tsapas, A.(2,4,5);
(1)Hippokration Hospital, Gastroenterology Division-Second Propaedeutic Department of Internal Medicine - Medical School - Aristotle University of Thessaloniki, Thessaloniki, Greece;(2)Clinical Research and Evidence-Based Medicine Unit, Second Medical Department- Aristotle University of Thessaloniki, Thessaloniki, Greece;(3)First Department of Internal Medicine, “Papageorgiou” Hospital, Thessaloniki, Greece;(4)Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece;(5)Harris Manchester College, University of Oxford, Oxford, United Kingdom;This study was funded by a research grant 2020EOMIFNEp5 from the Hellenic Group for the Study of IBD (EOMIFNE)
P1078: The influence of different 5-aminosalicylic acid preparations on mercaptopurine metabolismECCO'24Year: 2024
Authors: AnjieMD, S.(1)*;Hettinga, J.(1);Volkers, A.G.(1);van Gennep, S.(1);Clasquin, E.(1);Duijvestein, M.(2);van Bodegraven, A.A.(3);van der Zanden, E.P.(4);Jansen, J.M.(5);van Asseldonk, D.P.(6);West, R.L.(7);D@E@Haens, G.R.A.M.(1);Löwenberg, M.(1);de Boer, N.K.(8);
(1)Amsterdam UMC, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Radboudumc, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;(3)Zuyderland, Department of Gastroenterology and Hepatology, Sittard-Geleen, The Netherlands;(4)Ziekenhuis Amstelland, Department of Gastroenterology and Hepatology, Amstelveen, The Netherlands;(5)OLVG, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(6)Noordwest Ziekenhuisgroep, Department of Gastroenterology and Hepatology, Alkmaar, The Netherlands;(7)Franciscus Gasthuis, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands;(8)Amsterdam Gastroenterology Endocrinology Metabolism Research Institute- Amsterdam University Medical Centre- Vrije Universiteit Amsterdam- Amsterdam- The Netherlands, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;
P1079: Mindfulness-based cognitive therapy to reduce psychological distress in patients with Inflammatory Bowel Disease: first results of a multicentre randomised controlled trial (MindIBD).ECCO'24Year: 2024
Authors: Ter Avest, M.(1,2,3)*;Speckens, A.(1,3);Dijkstra, G.(4);Dresler, M.(3);Bosman, S.(1,3);Horjus, C.(5);Römkens, T.(2);Witteman, E.(6);Van Dop, W.(7);Nissen, L.(2);Huijbers, M.(1);
(1)Radboud University Medical Centre, Department of Psychiatry- Centre for Mindfulness, Nijmegen, The Netherlands;(2)Jeroen Bosch Hospital, Department of Gastroenterology and Hepatology, @E@s-Hertogenbosch, The Netherlands;(3)Radboud University Medical Centre, Donders Institute for Brain- Cognition and Behaviour, Nijmegen, The Netherlands;(4)University Medical Centre Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;(5)Rijnstate Hospital, Department of Gastroenterology and Hepatology, Arnhem, The Netherlands;(6)Canisius Wilhelmina Hospital, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;(7)Radboud University Medical Centre, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;
P107: Comparing the Colonic Tissue Proteome of Active and Inactive Ulcerative ColitisECCO'24Year: 2024
Authors: Penner, R.(1)*;de Almeida, L.(2);Rosentreter, R.(3);Hirota, S.(4);Dufour, A.(2);Lu, C.(1);
(1)University of Calgary, Division of Gastroenterology and Hepatology- Department of Medicine- University of Calgary, Calgary, Canada;(2)University of Calgary, Department of Biochemistry and Molecular Biology- University of Calgary- Alberta, Calgary, Canada;(3)University of Calgary, Division of Gastroenterology and Hepatology- Department of Medicine- University of Calgary1, Calagary, Canada;(4)University of Calgary, Department of Physiology & Pharmacology- University of Calgary- Alberta, Calgary, Canada;
P1080: Real-world Study on Early Predictors of Infliximab Treatment Efficacy in Crohn@E@s diseaseECCO'24Year: 2024
Authors: Lv, C.(1)*;Chen, Y.(2);Yan, F.(3);Pi, S.(2);Liu, Y.(2);Chen, R.(1);Tang, W.(1);Zhang, H.(3);
(1)The Second Affiliated Hospital of Soochow University, Gastroenterology, Suzhou, China;(2)Suzhou Medical College of Soochow University, Pathology- School of Biology and Basic Medical Sciences, Suzhou, China;(3)The First Affiliated Hospital of Nanjing Medical University, Gastroenterology, Nanjing, China;
P1081: Pharmacokinetics and immunogenicity of the ustekinumab biosimilar candidate ABP 654 in patients with moderate-to-severe plaque psoriasisECCO'24Year: 2024
Authors: Chow, V.(1)*;Mytych, D.T.(1);Blauvelt, A.(2);Papp, K.(3);Barragan, C.(1);Yamauchi, P.(4);Crowley, J.(5);Franklin, J.(1);
(1)Amgen Inc, Biosimilars Business Unit, Thousand Oaks, United States;(2)Oregon Medical Research Center, Oregon Medical Research Center, Portland, United States;(3)Alliance Clinical Trials Probity Medical Research, Alliance Clinical Trials Probity Medical Research, Waterloo, Canada;(4)Dermatology Institute & Skin Care Center- Inc., Clinical Science Institute, Santa Monica, United States;(5)Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield, United States;
